Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 1665

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 10
Chunk 1665
---
.64 or Below 
     2,357,124  
     4.63  
    $3.55  
     2,357,124  
    $3.55 

The detail of the warrants outstanding and exercisable as of March
31, 2024 is as follows:

    Warrants Outstanding  
    Warrants Exercisable 
  
    Range of  Exercise Prices 
    Number  Outstanding  
    Weighted Average  Remaining  Life (Years)  
    Weighted  Average  Exercise Price  
    Number  Outstanding  
    Weighted  Average  Exercise Price 
  
    $150.00 or Below 
     2,531  
     0.71  
    $125.28  
     2,531  
    $125.28 
  
    $200.00 - $220.00 
     1,559  
     0.81  
    $218.24  
     1,559  
    $218.24 

     4,090  

     4,090  

     F-19 

STOCK-BASED COMPENSATION:

2020 EQUITY INCENTIVE PLAN

The
2020 Equity Incentive Plan (the “2020 Plan”) was approved by our stockholders in September 2020 to provide stock-based incentives
to attract, retain, and motivate employees, directors, and consultants. The plan initially authorized 21,023 shares of common stock for
issuance through stock options, restricted stock units (RSUs), stock bonuses, stock appreciation rights, and other awards. Stockholders
approved increases to the share reserve in September 2022 and September 2024, authorizing an additional 22,500 and 375,000 shares, respectively.
As of March 31, 2025, 390,950 shares remained available for issuance under the 2020 Plan.

NON-EMPLOYEE DIRECTOR COMPENSATION POLICY

The Company maintains the Director Compensation
Policy which provides for cash and equity compensation for persons serving as non-employee directors of the Company. Under this policy,
each new non-employee director receives either stock options or a grant of RSUs upon appointment/election, as well as either an annual
grant of stock options or of RSUs at the beginning of each fiscal year. The (i) stock options are subject to vesting and (ii)